South Dakota State Senators want to make medical marijuana more accessible to those suffering from “debilitating medical conditions.” The Senate’s Health and Human Services... South Dakota Senate committee passes bill that would allow for wider use of medical cannabis

South Dakota State Senators want to make medical marijuana more accessible to those suffering from “debilitating medical conditions.”

The Senate’s Health and Human Services committee voted 6 to 1 Wednesday morning to advance SB 1, which would “modify (the) debilitating medical conditions for medical cannabis use.”

Amongst those conditions are glaucoma, multiple sclerosis, PTSD, and Crohn’s disease.

Sen. Julie Frye-Mueller (R-Rapid City), the lone no vote against the bill, raised concerns about making cannabis more accessible, particularly without FDA approval.

“We shouldn’t be taking the place of the FDA,” Frye-Mueller said in opposition. “This is serious stuff and I understand why some people want it, but this goes further than that.”

The bill was a product of the “Medical Marijuana Oversight Committee,” which met in the interim after the 2022 legislative session. That committee is made up of state lawmakers and officials, law enforcement officers, medical professionals, and industry experts from across the state.

Others who testified against the bill, including a lobbyist for “Protecting South Dakota Kids,” raised concerns about specific conditions written into the bill. A doctor from Vance Thompson in Sioux Falls argued that treating glaucoma with medical marijuana was not best practice.

[Read more at Dakota News Now]

MJ Shareholders avatar

MJ Shareholders

MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers

No comments so far.

Be first to leave comment below.

( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )